National Vaccine Injury Compensation Program; List of Petitions Received, 15196-15198 [2020-05525]
Download as PDF
<![CDATA[
15196
Federal Register / Vol. 85, No. 52 / Tuesday, March 17, 2020 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
knowingly and intentionally attempting
to import into the United States a
mixture and substance containing a
detectable amount of gammaHydroxybutyric Acid, a Schedule I
controlled substance in violation of 21
U.S.C. 952(a), 960(a)(1), 960(b)(3), and
963 on or about April 16, 2018, as
described in the Superseding
Indictment in his case dated October 10,
2018.
As a result of this conviction, FDA
sent Mr. Jodoin by certified mail on
September 25, 2019, a notice proposing
to debar him for 5 years from importing
or offering for import any drug into the
United States. The proposal was based
on a finding under section 306(b)(3)(C)
of the FD&C Act that Mr. Jodoin’s felony
conviction was for conduct relating to
the importation into the United States of
any drug or controlled substance
because he smuggled into the United
States a Schedule I controlled
substance. In proposing a debarment
period, FDA weighed the considerations
set forth in section 306(c)(3) of the
FD&C Act that it considered applicable
to Mr. Jodoin’s offense and concluded
Mr. Jodoin’s felony offense warranted a
5-year period of debarment.
The proposal informed Mr. Jodoin of
the proposed debarment and offered Mr.
Jodoin an opportunity to request a
hearing, providing him 30 days from the
date of receipt of the letter in which to
file the request, and advised him that
failure to request a hearing constituted
a waiver of the opportunity for a hearing
and of any contentions concerning this
action. Mr. Jodoin received the proposal
and notice of opportunity for a hearing
on October 8, 2019. Mr. Jodoin failed to
request a hearing within the timeframe
prescribed by regulation and has,
therefore, waived his opportunity for a
hearing and waived any contentions
concerning his debarment (21 CFR part
12).
II. Findings and Order
Therefore, the Assistant
Commissioner, Office of Human and
Animal Food Operations, under section
306(b)(3)(C) of the FD&C Act, under
authority delegated to the Assistant
Commissioner, finds that Mr. Jodoin has
been convicted of a felony under
Federal law for conduct relating to the
importation into the United States of
any drug or controlled substance. FDA
finds that this offense should be
accorded a debarment period of 5 years.
As a result of the foregoing finding,
Mr. Jodoin is debarred for a period of 5
years from importing or offering for
import any drug into the United States,
effective (see DATES). Pursuant to
section 301(cc) of the FD&C Act (21
VerDate Sep<11>2014
17:32 Mar 16, 2020
Jkt 250001
U.S.C. 331(cc)), the importing or
offering for import into the United
States of any drug or controlled
substance by, with the assistance of, or
at the direction of Mr. Jodoin is a
prohibited act.
Any application by Mr. Jodoin for
termination of debarment under section
306(d)(1) of the FD&C Act should be
identified with Docket No. FDA–2019–
N–2734 and sent to the Dockets
Management Staff (see ADDRESSES). All
such submissions are to be filed in four
copies. The public availability of
information in these submissions is
governed by 21 CFR 10.20.
Publicly available submissions will be
placed in the docket and will be
viewable at https://www.regulations.gov
or at the Dockets Management Staff (see
ADDRESSES) between 9 a.m. and 4 p.m.,
Monday through Friday.
Dated: March 11, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–05444 Filed 3–16–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Vaccine Injury Compensation
Program; List of Petitions Received
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
HRSA is publishing this
notice of petitions received under the
National Vaccine Injury Compensation
Program (the Program), as required of
the Public Health Service (PHS) Act, as
amended. While the Secretary of HHS is
named as the respondent in all
proceedings brought by the filing of
petitions for compensation under the
Program, the United States Court of
Federal Claims is charged by statute
with responsibility for considering and
acting upon the petitions.
FOR FURTHER INFORMATION CONTACT: For
information about requirements for
filing petitions, and the Program in
general, contact Lisa L. Reyes, Clerk of
Court, United States Court of Federal
Claims, 717 Madison Place NW,
Washington, DC 20005, (202) 357–6400.
For information on HRSA’s role in the
Program, contact the Director, National
Vaccine Injury Compensation Program,
5600 Fishers Lane, Room 08N146B,
Rockville, Maryland 20857; (301) 443–
6593, or visit our website at: https://
SUMMARY:
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
www.hrsa.gov/vaccinecompensation/
index.html.
The
Program provides a system of no-fault
compensation for certain individuals
who have been injured by specified
childhood vaccines. Subtitle 2 of Title
XXI of the PHS Act, 42 U.S.C. 300aa–
10 et seq., provides that those seeking
compensation are to file a petition with
the United States Court of Federal
Claims and to serve a copy of the
petition to the Secretary of HHS, who is
named as the respondent in each
proceeding. The Secretary has delegated
this responsibility under the Program to
HRSA. The Court is directed by statute
to appoint special masters who take
evidence, conduct hearings as
appropriate, and make initial decisions
as to eligibility for, and amount of,
compensation.
A petition may be filed with respect
to injuries, disabilities, illnesses,
conditions, and deaths resulting from
vaccines described in the Vaccine Injury
Table (the Table) set forth at 42 CFR
100.3. This Table lists for each covered
childhood vaccine the conditions that
may lead to compensation and, for each
condition, the time period for
occurrence of the first symptom or
manifestation of onset or of significant
aggravation after vaccine
administration. Compensation may also
be awarded for conditions not listed in
the Table and for conditions that are
manifested outside the time periods
specified in the Table, but only if the
petitioner shows that the condition was
caused by one of the listed vaccines.
Section 2112(b)(2) of the PHS Act, 42
U.S.C. 300aa–12(b)(2), requires that
‘‘[w]ithin 30 days after the Secretary
receives service of any petition filed
under section 2111 the Secretary shall
publish notice of such petition in the
Federal Register.’’ Set forth below is a
list of petitions received by HRSA on
February 1, 2020, through February 29,
2020. This list provides the name of
petitioner, city and state of vaccination
(if unknown then city and state of
person or attorney filing claim), and
case number. In cases where the Court
has redacted the name of a petitioner
and/or the case number, the list reflects
such redaction.
Section 2112(b)(2) also provides that
the special master ‘‘shall afford all
interested persons an opportunity to
submit relevant, written information’’
relating to the following:
1. The existence of evidence ‘‘that
there is not a preponderance of the
evidence that the illness, disability,
injury, condition, or death described in
the petition is due to factors unrelated
SUPPLEMENTARY INFORMATION:
E:\FR\FM\17MRN1.SGM
17MRN1
Federal Register / Vol. 85, No. 52 / Tuesday, March 17, 2020 / Notices
to the administration of the vaccine
described in the petition,’’ and
2. Any allegation in a petition that the
petitioner either:
a. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition not set forth in the
Vaccine Injury Table but which was
caused by’’ one of the vaccines referred
to in the Table, or
b. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition set forth in the
Vaccine Injury Table the first symptom
or manifestation of the onset or
significant aggravation of which did not
occur within the time period set forth in
the Table but which was caused by a
vaccine’’ referred to in the Table.
In accordance with Section
2112(b)(2), all interested persons may
submit written information relevant to
the issues described above in the case of
the petitions listed below. Any person
choosing to do so should file an original
and three (3) copies of the information
with the Clerk of the United States
Court of Federal Claims at the address
listed above (under the heading FOR
FURTHER INFORMATION CONTACT), with a
copy to HRSA addressed to Director,
Division of Injury Compensation
Programs, Healthcare Systems Bureau,
5600 Fishers Lane, 08N146B, Rockville,
Maryland 20857. The Court’s caption
(Petitioner’s Name v. Secretary of HHS)
and the docket number assigned to the
petition should be used as the caption
for the written submission. Chapter 35
of title 44, United States Code, related
to paperwork reduction, does not apply
to information required for purposes of
carrying out the Program.
Dated: March 11, 2020.
Thomas J. Engels,
Administrator.
khammond on DSKJM1Z7X2PROD with NOTICES
List of Petitions Filed
1. Megan Sebasky, Madison, Wisconsin,
Court of Federal Claims No: 20–0122V
2. Dorothy Stradford, Hillside, New Jersey,
Court of Federal Claims No: 20–0124V
3. Tammie Attaway, Salinas, California,
Court of Federal Claims No: 20–0125V
4. Linda Fletcher, Port St. Lucie, Florida,
Court of Federal Claims No: 20–0127V
5. Michael Cook, Zionsville, Indiana, Court of
Federal Claims No: 20–0128V
6. Tammy Kleyle on behalf of A. N. K.,
Marrero, Louisiana, Court of Federal
Claims No: 20–0129V
7. Julia Conroy, Tucson, Arizona, Court of
Federal Claims No: 20–0131V
8. Edwin John Sherry and Kimberly Diane
Sherry on behalf of Anjalie Leana-Rose
Sherry, Deceased, Charlotte, North
Carolina, Court of Federal Claims No:
20–0132V
9. Dan Noel and Haley Noel on behalf of H.
N., Colorado Springs, Colorado, Court of
VerDate Sep<11>2014
17:32 Mar 16, 2020
Jkt 250001
Federal Claims No: 20–0134V
10. Ronald Piccolotti, Dallas, Texas, Court of
Federal Claims No: 20–0135V
11. Christine Schultz, Frederick, Maryland,
Court of Federal Claims No: 20–0136V
12. Katherine Mensinger on behalf of The
Estate of Thomas Mensinger, Deceased,
Benton Harbor, Michigan, Court of
Federal Claims No: 20–0138V
13. Katelyn Uglialoro on behalf of LinMarie
Uglialoro, Hershey, Pennsylvania, Court
of Federal Claims No: 20–0139V
14. Carol Joan Gonzales, Puyallup,
Washington, Court of Federal Claims No:
20–0140V
15. Neil Silver, New York, New York, Court
of Federal Claims No: 20–0141V
16. Jeffrey E. Olson, Deceased, Waupun,
Wisconsin, Court of Federal Claims No:
20–0142V
17. Joel Miles, Green Bay, Wisconsin, Court
of Federal Claims No: 20–0146V
18. Enye McHugh on behalf of S. M.,
Madison, Wisconsin, Court of Federal
Claims No: 20–0148V
19. Francis E. Sethman, Jr., Greensboro,
North Carolina, Court of Federal Claims
No: 20–0149V
20. Nancy Bender-Kelner, Shorewood,
Minnesota, Court of Federal Claims No:
20–0151V
21. Maureen Miller, Berkeley, California,
Court of Federal Claims No: 20–0152V
22. Sarah Eichorn, Des Moines, Iowa, Court
of Federal Claims No: 20–0154V
23. Rebecca Viancourt, Cleveland, Ohio,
Court of Federal Claims No: 20–0155V
24. Heidi M. Brill on behalf of A. B., Fond
du Lac, Wisconsin, Court of Federal
Claims No: 20–0156V
25. Mario A. Flores, Jr., Harlingen, Texas,
Court of Federal Claims No: 20–0157V
26. Pamela M. Leathers, Camas, Washington,
Court of Federal Claims No: 20–0162V
27. Ania Oliva-Guedes, Rochester, New York,
Court of Federal Claims No: 20–0165V
28. Julie Lechner, Aberdeen, South Dakota,
Court of Federal Claims No: 20–0170V
29. Helane Stein, Conshohocken,
Pennsylvania, Court of Federal Claims
No: 20–0171V
30. Lee Ann Sender, Washington, District of
Columbia, Court of Federal Claims No:
20–0172V
31. Jeffrey Horning, Washington, District of
Columbia, Court of Federal Claims No:
20–0173V
32. Jakeisha Saville, Dallas, Texas, Court of
Federal Claims No: 20–0174V
33. Robert Introini, Mansfield,
Massachusetts, Court of Federal Claims
No: 20–0176V
34. Dustin Gibson, Humboldt, Iowa, Court of
Federal Claims No: 20–0177V
35. Kamalika Saha, Cambridge,
Massachusetts, Court of Federal Claims
No: 20–0178V
36. Leticia Palencia on behalf of C. A. P.,
Harlingen, Texas, Court of Federal
Claims No: 20–0180V
37. John Gavin, Washington, District of
Columbia, Court of Federal Claims No:
20–0181V
38. Hilary Harris, Washington, District of
Columbia, Court of Federal Claims No:
20–0182V
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
15197
39. John Holloway, Oakland, California,
Court of Federal Claims No: 20–0184V
40. Marylou LaLonde, Boston, Massachusetts,
Court of Federal Claims No: 20–0186V
41. Gary Allen, Idaho Springs, Colorado,
Court of Federal Claims No: 20–0187V
42. Rina Schnaufer, Rochester, New York,
Court of Federal Claims No: 20–0189V
43. Rodney Koehl, Peoria, Illinois, Court of
Federal Claims No: 20–0190V
44. Gelacio Valdez, Dixon, Illinois, Court of
Federal Claims No: 20–0191V
45. Montana Smithey on behalf of E. S.,
Burlington, North Carolina, Court of
Federal Claims No: 20–0192V
46. Joseph Dweck, Brooklyn, New York,
Court of Federal Claims No: 20–0193V
47. Jennifer Bonilla-Edgington, Stroudsburg,
Pennsylvania, Court of Federal Claims
No: 20–0194V
48. Brenda Anderson, Grand Rapids,
Michigan, Court of Federal Claims No:
20–0195V
49. Betty A. Dennis on behalf of Estate of
Richard P. Dennis, Deceased, La Crosse,
Wisconsin, Court of Federal Claims No:
20–0198V
50. Nicole Matley, Monroe, Wisconsin, Court
of Federal Claims No: 20–0199V
51. Betty Davis, Decatur, Texas, Court of
Federal Claims No: 20–0201V
52. Esther Reeves, Naples, Florida, Court of
Federal Claims No: 20–0202V
53. Sandeep Bains, Abington, Pennsylvania,
Court of Federal Claims No: 20–0203V
54. John Davenport, Tucson, Arizona, Court
of Federal Claims No: 20–0206V
55. Phyllis Doyle, Seattle, Washington, Court
of Federal Claims No: 20–0207V
56. David Carpenter, Jr., Nashville,
Tennessee, Court of Federal Claims No:
20–0208V
57. Tracy Sue Beach, Newark, Ohio, Court of
Federal Claims No: 20–0209V
58. Lindsay Corum on behalf of the Estate of
Stephen M. Corum, Deceased on behalf
of the Estate of Marshall Wayne Corum,
Deceased, Henderson, Kentucky, Court
of Federal Claims No: 20–0210V
59. Trina Lower, Moose Lake, Minnesota,
Court of Federal Claims No: 20–0211V
60. Robert Clendaniel, Millville, New Jersey,
Court of Federal Claims No: 20–0213V
61. Wayne Phillip Anderson, Bellevue,
Washington, Court of Federal Claims No:
20–0214V
62. Patricia Alex Freeman, North Bend,
Washington, Court of Federal Claims No:
20–0215V
63. Raymond Small, Harleysville,
Pennsylvania, Court of Federal Claims
No: 20–0216V
64. Susie Bjalobok, Pittsburgh, Pennsylvania,
Court of Federal Claims No: 20–0217V
65. Jennifer Kilgrow, Salt Lake City, Utah,
Court of Federal Claims No: 20–0218V
66. Ignacio Montes, Fontana, California,
Court of Federal Claims No: 20–0219V
67. Adam Mackay, Dresher, Pennsylvania,
Court of Federal Claims No: 20–0220V
68. Patricia Lopez, Brownsville, Texas, Court
of Federal Claims No: 20–0223V
69. Selina Villafranca on behalf of N. L. V.,
Brownsville, Texas, Court of Federal
Claims No: 20–0224V
70. Kim Warner on behalf of D. W., Dublin,
E:\FR\FM\17MRN1.SGM
17MRN1
15198
Federal Register / Vol. 85, No. 52 / Tuesday, March 17, 2020 / Notices
Ohio, Court of Federal Claims No: 20–
0225V
71. Shannon Pyers, Dresher, Pennsylvania,
Court of Federal Claims No: 20–0231V
72. Lisa Macon, Englewood, New Jersey,
Court of Federal Claims No: 20–0232V
[FR Doc. 2020–05525 Filed 3–16–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Declaration Under the Public
Readiness and Emergency
Preparedness Act for Medical
Countermeasures Against COVID–19
ACTION:
Notice of declaration.
The Secretary is issuing this
Declaration pursuant to section 319F–3
of the Public Health Service Act to
provide liability immunity for activities
related to medical countermeasures
against COVID–19.
DATES: The Declaration was effective as
of February 4, 2020.
FOR FURTHER INFORMATION CONTACT:
Robert P. Kadlec, MD, MTM&H, MS,
Assistant Secretary for Preparedness
and Response, Office of the Secretary,
Department of Health and Human
Services, 200 Independence Avenue
SW, Washington, DC 20201; Telephone:
202–205–2882.
SUPPLEMENTARY INFORMATION: The
Public Readiness and Emergency
Preparedness Act (PREP Act) authorizes
the Secretary of Health and Human
Services (the Secretary) to issue a
Declaration to provide liability
immunity to certain individuals and
entities (Covered Persons) against any
claim of loss caused by, arising out of,
relating to, or resulting from the
manufacture, distribution,
administration, or use of medical
countermeasures (Covered
Countermeasures), except for claims
involving ‘‘willful misconduct’’ as
defined in the PREP Act. This
Declaration is subject to amendment as
circumstances warrant.
The PREP Act was enacted on
December 30, 2005, as Public Law 109–
148, Division C, Section 2. It amended
the Public Health Service (PHS) Act,
adding Section 319F–3, which
addresses liability immunity, and
Section 319F–4, which creates a
compensation program. These sections
are codified at 42 U.S.C. 247d-6d and 42
U.S.C. 247d–6e, respectively.
The Pandemic and All-Hazards
Preparedness Reauthorization Act
(PAHPRA), Public Law 113–5, was
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:32 Mar 16, 2020
Jkt 250001
enacted on March 13, 2013. Among
other things, PAHPRA added sections
564A and 564B to the Federal Food,
Drug, and Cosmetic (FD&C) Act to
provide new authorities for the
emergency use of approved products in
emergencies and products held for
emergency use. PAHPRA accordingly
amended the definitions of ‘‘Covered
Countermeasures’’ and ‘‘qualified
pandemic and epidemic products’’ in
Section 319F–3 of the Public Health
Service Act (PREP Act provisions), so
that products made available under
these new FD&C Act authorities could
be covered under PREP Act
Declarations. PAHPRA also extended
the definition of qualified pandemic and
epidemic products that may be covered
under a PREP Act Declaration to include
products or technologies intended to
enhance the use or effect of a drug,
biological product, or device used
against the pandemic or epidemic or
against adverse events from these
products.
COVID–19 is an acute respiratory
disease caused by the SARS-CoV-2
betacoronavirus or a virus mutating
therefrom. This virus is similar to other
betacoronaviruses, such as Middle
Eastern Respiratory Syndrome (MERS)
and Severe Acute Respiratory Syndrome
(SARS). Although the complete clinical
picture regarding SARS-CoV-2 or a virus
mutating therefrom is not fully
understood, the virus has been known
to cause severe respiratory illness and
death in a subset of those people
infected with such virus(es).
In December 2019, the novel
coronavirus was detected in Wuhan
City, Hubei Province, China. Today,
over 101 countries, including the United
States have reported multiple cases.
Acknowledging that cases had been
reported in five WHO regions in one
month, on January 30, 2020, WHO
declared the COVID–19 outbreak to be
a Public Health Emergency of
International Concern (PHEIC) following
a second meeting of the Emergency
Committee convened under the
International Health Regulations (IHR).
To date, United States travelerassociated cases have been identified in
a number of States and communitybased transmission is suspected. On
January 31, 2020, Secretary Azar
declared a public health emergency
pursuant to section 319 of the PHS Act,
42 U.S.C. 247d, for the entire United
States to aid in the nation’s health care
community response to the COVID–19
outbreak.1 The outbreak remains a
significant public health challenge that
1 https://www.phe.gov/emergency/news/
healthactions/phe/Pages/2019-nCoV.aspx.
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
requires a sustained, coordinated
proactive response by the Government
in order to contain and mitigate the
spread of COVID–19.2
Description of This Declaration by
Section
Section I. Determination of Public
Health Emergency or Credible Risk of
Future Public Health Emergency
Before issuing a Declaration under the
PREP Act, the Secretary is required to
determine that a disease or other health
condition or threat to health constitutes
a public health emergency or that there
is a credible risk that the disease,
condition, or threat may constitute such
an emergency. This determination is
separate and apart from the Declaration
issued by the Secretary on January 31,
2020 under Section 319 of the PHS Act
that a disease or disorder presents a
public health emergency or that a public
health emergency, including significant
outbreaks of infectious diseases or
bioterrorist attacks, otherwise exists, or
other Declarations or determinations
made under other authorities of the
Secretary. Accordingly in Section I of
the Declaration, the Secretary
determines that the spread of SARSCoV-2 or a virus mutating therefrom and
the resulting disease, COVID–19,
constitutes a public health emergency
for purposes of this Declaration under
the PREP Act.
Section II. Factors Considered by the
Secretary
In deciding whether and under what
circumstances to issue a Declaration
with respect to a Covered
Countermeasure, the Secretary must
consider the desirability of encouraging
the design, development, clinical testing
or investigation, manufacture, labeling,
distribution, formulation, packaging,
marketing, promotion, sale, purchase,
donation, dispensing, prescribing,
administration, licensing, and use of the
countermeasure. In Section II of the
Declaration, the Secretary states that he
has considered these factors.
Section III. Activities Covered by This
Declaration Under the PREP Act’s
Liability Immunity
The Secretary must delineate the
activities for which the PREP Act’s
liability immunity is in effect. These
activities may include, under conditions
as the Secretary may specify, the
manufacture, testing, development,
distribution, administration, or use of
one or more Covered Countermeasures
2 CDC COVID–19 Summary; https://www.cdc.gov/
coronavirus/2019-ncov/summary.html, accessed
27Feb2020,
E:\FR\FM\17MRN1.SGM
17MRN1
]]>Agencies
[Federal Register Volume 85, Number 52 (Tuesday, March 17, 2020)]
[Notices]
[Pages 15196-15198]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05525]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Vaccine Injury Compensation Program; List of Petitions
Received
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: HRSA is publishing this notice of petitions received under the
National Vaccine Injury Compensation Program (the Program), as required
of the Public Health Service (PHS) Act, as amended. While the Secretary
of HHS is named as the respondent in all proceedings brought by the
filing of petitions for compensation under the Program, the United
States Court of Federal Claims is charged by statute with
responsibility for considering and acting upon the petitions.
FOR FURTHER INFORMATION CONTACT: For information about requirements for
filing petitions, and the Program in general, contact Lisa L. Reyes,
Clerk of Court, United States Court of Federal Claims, 717 Madison
Place NW, Washington, DC 20005, (202) 357-6400. For information on
HRSA's role in the Program, contact the Director, National Vaccine
Injury Compensation Program, 5600 Fishers Lane, Room 08N146B,
Rockville, Maryland 20857; (301) 443-6593, or visit our website at:
https://www.hrsa.gov/vaccinecompensation/.
SUPPLEMENTARY INFORMATION: The Program provides a system of no-fault
compensation for certain individuals who have been injured by specified
childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C.
300aa-10 et seq., provides that those seeking compensation are to file
a petition with the United States Court of Federal Claims and to serve
a copy of the petition to the Secretary of HHS, who is named as the
respondent in each proceeding. The Secretary has delegated this
responsibility under the Program to HRSA. The Court is directed by
statute to appoint special masters who take evidence, conduct hearings
as appropriate, and make initial decisions as to eligibility for, and
amount of, compensation.
A petition may be filed with respect to injuries, disabilities,
illnesses, conditions, and deaths resulting from vaccines described in
the Vaccine Injury Table (the Table) set forth at 42 CFR 100.3. This
Table lists for each covered childhood vaccine the conditions that may
lead to compensation and, for each condition, the time period for
occurrence of the first symptom or manifestation of onset or of
significant aggravation after vaccine administration. Compensation may
also be awarded for conditions not listed in the Table and for
conditions that are manifested outside the time periods specified in
the Table, but only if the petitioner shows that the condition was
caused by one of the listed vaccines.
Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa-12(b)(2),
requires that ``[w]ithin 30 days after the Secretary receives service
of any petition filed under section 2111 the Secretary shall publish
notice of such petition in the Federal Register.'' Set forth below is a
list of petitions received by HRSA on February 1, 2020, through
February 29, 2020. This list provides the name of petitioner, city and
state of vaccination (if unknown then city and state of person or
attorney filing claim), and case number. In cases where the Court has
redacted the name of a petitioner and/or the case number, the list
reflects such redaction.
Section 2112(b)(2) also provides that the special master ``shall
afford all interested persons an opportunity to submit relevant,
written information'' relating to the following:
1. The existence of evidence ``that there is not a preponderance of
the evidence that the illness, disability, injury, condition, or death
described in the petition is due to factors unrelated
[[Page 15197]]
to the administration of the vaccine described in the petition,'' and
2. Any allegation in a petition that the petitioner either:
a. ``[S]ustained, or had significantly aggravated, any illness,
disability, injury, or condition not set forth in the Vaccine Injury
Table but which was caused by'' one of the vaccines referred to in the
Table, or
b. ``[S]ustained, or had significantly aggravated, any illness,
disability, injury, or condition set forth in the Vaccine Injury Table
the first symptom or manifestation of the onset or significant
aggravation of which did not occur within the time period set forth in
the Table but which was caused by a vaccine'' referred to in the Table.
In accordance with Section 2112(b)(2), all interested persons may
submit written information relevant to the issues described above in
the case of the petitions listed below. Any person choosing to do so
should file an original and three (3) copies of the information with
the Clerk of the United States Court of Federal Claims at the address
listed above (under the heading For Further Information Contact), with
a copy to HRSA addressed to Director, Division of Injury Compensation
Programs, Healthcare Systems Bureau, 5600 Fishers Lane, 08N146B,
Rockville, Maryland 20857. The Court's caption (Petitioner's Name v.
Secretary of HHS) and the docket number assigned to the petition should
be used as the caption for the written submission. Chapter 35 of title
44, United States Code, related to paperwork reduction, does not apply
to information required for purposes of carrying out the Program.
Dated: March 11, 2020.
Thomas J. Engels,
Administrator.
List of Petitions Filed
1. Megan Sebasky, Madison, Wisconsin, Court of Federal Claims No:
20-0122V
2. Dorothy Stradford, Hillside, New Jersey, Court of Federal Claims
No: 20-0124V
3. Tammie Attaway, Salinas, California, Court of Federal Claims No:
20-0125V
4. Linda Fletcher, Port St. Lucie, Florida, Court of Federal Claims
No: 20-0127V
5. Michael Cook, Zionsville, Indiana, Court of Federal Claims No:
20-0128V
6. Tammy Kleyle on behalf of A. N. K., Marrero, Louisiana, Court of
Federal Claims No: 20-0129V
7. Julia Conroy, Tucson, Arizona, Court of Federal Claims No: 20-
0131V
8. Edwin John Sherry and Kimberly Diane Sherry on behalf of Anjalie
Leana-Rose Sherry, Deceased, Charlotte, North Carolina, Court of
Federal Claims No: 20-0132V
9. Dan Noel and Haley Noel on behalf of H. N., Colorado Springs,
Colorado, Court of Federal Claims No: 20-0134V
10. Ronald Piccolotti, Dallas, Texas, Court of Federal Claims No:
20-0135V
11. Christine Schultz, Frederick, Maryland, Court of Federal Claims
No: 20-0136V
12. Katherine Mensinger on behalf of The Estate of Thomas Mensinger,
Deceased, Benton Harbor, Michigan, Court of Federal Claims No: 20-
0138V
13. Katelyn Uglialoro on behalf of LinMarie Uglialoro, Hershey,
Pennsylvania, Court of Federal Claims No: 20-0139V
14. Carol Joan Gonzales, Puyallup, Washington, Court of Federal
Claims No: 20-0140V
15. Neil Silver, New York, New York, Court of Federal Claims No: 20-
0141V
16. Jeffrey E. Olson, Deceased, Waupun, Wisconsin, Court of Federal
Claims No: 20-0142V
17. Joel Miles, Green Bay, Wisconsin, Court of Federal Claims No:
20-0146V
18. Enye McHugh on behalf of S. M., Madison, Wisconsin, Court of
Federal Claims No: 20-0148V
19. Francis E. Sethman, Jr., Greensboro, North Carolina, Court of
Federal Claims No: 20-0149V
20. Nancy Bender-Kelner, Shorewood, Minnesota, Court of Federal
Claims No: 20-0151V
21. Maureen Miller, Berkeley, California, Court of Federal Claims
No: 20-0152V
22. Sarah Eichorn, Des Moines, Iowa, Court of Federal Claims No: 20-
0154V
23. Rebecca Viancourt, Cleveland, Ohio, Court of Federal Claims No:
20-0155V
24. Heidi M. Brill on behalf of A. B., Fond du Lac, Wisconsin, Court
of Federal Claims No: 20-0156V
25. Mario A. Flores, Jr., Harlingen, Texas, Court of Federal Claims
No: 20-0157V
26. Pamela M. Leathers, Camas, Washington, Court of Federal Claims
No: 20-0162V
27. Ania Oliva-Guedes, Rochester, New York, Court of Federal Claims
No: 20-0165V
28. Julie Lechner, Aberdeen, South Dakota, Court of Federal Claims
No: 20-0170V
29. Helane Stein, Conshohocken, Pennsylvania, Court of Federal
Claims No: 20-0171V
30. Lee Ann Sender, Washington, District of Columbia, Court of
Federal Claims No: 20-0172V
31. Jeffrey Horning, Washington, District of Columbia, Court of
Federal Claims No: 20-0173V
32. Jakeisha Saville, Dallas, Texas, Court of Federal Claims No: 20-
0174V
33. Robert Introini, Mansfield, Massachusetts, Court of Federal
Claims No: 20-0176V
34. Dustin Gibson, Humboldt, Iowa, Court of Federal Claims No: 20-
0177V
35. Kamalika Saha, Cambridge, Massachusetts, Court of Federal Claims
No: 20-0178V
36. Leticia Palencia on behalf of C. A. P., Harlingen, Texas, Court
of Federal Claims No: 20-0180V
37. John Gavin, Washington, District of Columbia, Court of Federal
Claims No: 20-0181V
38. Hilary Harris, Washington, District of Columbia, Court of
Federal Claims No: 20-0182V
39. John Holloway, Oakland, California, Court of Federal Claims No:
20-0184V
40. Marylou LaLonde, Boston, Massachusetts, Court of Federal Claims
No: 20-0186V
41. Gary Allen, Idaho Springs, Colorado, Court of Federal Claims No:
20-0187V
42. Rina Schnaufer, Rochester, New York, Court of Federal Claims No:
20-0189V
43. Rodney Koehl, Peoria, Illinois, Court of Federal Claims No: 20-
0190V
44. Gelacio Valdez, Dixon, Illinois, Court of Federal Claims No: 20-
0191V
45. Montana Smithey on behalf of E. S., Burlington, North Carolina,
Court of Federal Claims No: 20-0192V
46. Joseph Dweck, Brooklyn, New York, Court of Federal Claims No:
20-0193V
47. Jennifer Bonilla-Edgington, Stroudsburg, Pennsylvania, Court of
Federal Claims No: 20-0194V
48. Brenda Anderson, Grand Rapids, Michigan, Court of Federal Claims
No: 20-0195V
49. Betty A. Dennis on behalf of Estate of Richard P. Dennis,
Deceased, La Crosse, Wisconsin, Court of Federal Claims No: 20-0198V
50. Nicole Matley, Monroe, Wisconsin, Court of Federal Claims No:
20-0199V
51. Betty Davis, Decatur, Texas, Court of Federal Claims No: 20-
0201V
52. Esther Reeves, Naples, Florida, Court of Federal Claims No: 20-
0202V
53. Sandeep Bains, Abington, Pennsylvania, Court of Federal Claims
No: 20-0203V
54. John Davenport, Tucson, Arizona, Court of Federal Claims No: 20-
0206V
55. Phyllis Doyle, Seattle, Washington, Court of Federal Claims No:
20-0207V
56. David Carpenter, Jr., Nashville, Tennessee, Court of Federal
Claims No: 20-0208V
57. Tracy Sue Beach, Newark, Ohio, Court of Federal Claims No: 20-
0209V
58. Lindsay Corum on behalf of the Estate of Stephen M. Corum,
Deceased on behalf of the Estate of Marshall Wayne Corum, Deceased,
Henderson, Kentucky, Court of Federal Claims No: 20-0210V
59. Trina Lower, Moose Lake, Minnesota, Court of Federal Claims No:
20-0211V
60. Robert Clendaniel, Millville, New Jersey, Court of Federal
Claims No: 20-0213V
61. Wayne Phillip Anderson, Bellevue, Washington, Court of Federal
Claims No: 20-0214V
62. Patricia Alex Freeman, North Bend, Washington, Court of Federal
Claims No: 20-0215V
63. Raymond Small, Harleysville, Pennsylvania, Court of Federal
Claims No: 20-0216V
64. Susie Bjalobok, Pittsburgh, Pennsylvania, Court of Federal
Claims No: 20-0217V
65. Jennifer Kilgrow, Salt Lake City, Utah, Court of Federal Claims
No: 20-0218V
66. Ignacio Montes, Fontana, California, Court of Federal Claims No:
20-0219V
67. Adam Mackay, Dresher, Pennsylvania, Court of Federal Claims No:
20-0220V
68. Patricia Lopez, Brownsville, Texas, Court of Federal Claims No:
20-0223V
69. Selina Villafranca on behalf of N. L. V., Brownsville, Texas,
Court of Federal Claims No: 20-0224V
70. Kim Warner on behalf of D. W., Dublin,
[[Page 15198]]
Ohio, Court of Federal Claims No: 20-0225V
71. Shannon Pyers, Dresher, Pennsylvania, Court of Federal Claims
No: 20-0231V
72. Lisa Macon, Englewood, New Jersey, Court of Federal Claims No:
20-0232V
[FR Doc. 2020-05525 Filed 3-16-20; 8:45 am]
BILLING CODE 4165-15-P
